Seminars in Liver Disease

LinksSchließen

Referenz

Yau T, Kang YK, Kim TY. et al.
Efficacy and safety of nivolumab plus ipilimumab in patients with advanced hepatocellular carcinoma previously treated with sorafenib: the CheckMate 040 randomized clinical trial.

JAMA Oncol 2020;
6 (11) e204564

Bibliographische Angaben herunterladen

Aufrufen in: